References
- Swedres 2002. A report on Swedish antibiotic utilization and resistance in human medicine. Stockholm: The Swedish Strategic Programme for the Rational Use of Antimicrobial agents (STRAMA) and the Swedish Institute for Infectious Disease Control; 2003.
- Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–3.
- Smith RD, Coast J. Antimicrobial resistance: a global response. Bull World Health Organ 2002; 80: 126–33.
- Irwin DE, Weatherby LB, Huang WY, Rosenberg DM, Cook SF, Walker AM. Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv Res 2001; 1: 8.
- Pachucki CT. The diagnosis of influenza. Semin Respir Infect 1992; 7: 46–53.
- Nicholson KG. Clinical features of influenza. Semin Respir Infect 1992; 7: 26–37.
- Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000; 51: 407–21.
- Cox NJ, Subbarao K. Influenza. Lancet 1999; 354: 1277–82.
- Linde A, Kolmskog C, Brytting M, Wahren B, Bergren Palme I, Ekdahl K, et al. Annual Report: September 2000–August 2001. Stockholm: The National Influenza Reference Center, Swedish Institute for Infectious Disease Control; 2001.
- Tumova B, Hannoun C. Perspectives in influenza surveillance in Europe: European scientific working group on influenza, Brussels. Vaccine 2002; 20: S25–7.
- Kitler ME, Gavinio P, Lavanchy D. Influenza and the work of the World Health Organization. Vaccine 2002; 20: S5–14.
- Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest 2001; 119: 1717–23.
- Wiselka M. Influenza: diagnosis, management, and prophylaxis. BMJ 1994; 308: 1341–5.
- Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med 2000; 160: 3234–40.
- Mölstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 1999; 31: 191–5.
- SPSS for Windows. Version: 10.0.5. Chicago: SPSS Inc.; 1999.
- ATC Index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 1999.
- Diggle PJ. Analysis of longitudinal data. New ed. Oxford: Oxford University Press; 2001.
- Mölstad S, Stålsby Lundborg C, Karlsson A-K, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis 2002; 34: 366–71.
- Odenholt I, Bylander-Groth A, Frimodt-Möller N, Rokstad KS, Mölstad S. Differences in antibiotic prescribing patterns between general practitioners in Scandinavia: a questionnaire study. Scand J Infect Dis 2002; 34: 602–9.
- Andre M, Odenholt I, Schwan Å, and the Swedish Study Group on Antibiotic Use. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scand J Infect Dis 2002; 34: 860–80.
- Stålsby Lundborg C, Olsson E, Mölstad S, and the Swedish Study Group on Antibiotic Use. Antibiotic prescribing in outpatients: a 1-week diagnosis-prescribing study in 5 counties in Sweden. Scand J Infect Dis 2002; 34: 442–8.
- Bradley CP Decision making and prescribing patterns-a literature review. Fam Pract 1991; 8: 276–87.
- Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R. Treatment and prevention of influenza: Swedish recommendations. Scand J Infect Dis 2003; 35: 3–11.
- Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225–31.
- Belshe RB, Gruber WC. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1947–51.
- Noyola DE, Demmler GJ. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J 2000; 19: 303–7.